Stay updated on Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new page revision (v3.5.4) has been added. Older revision text (v3.5.3) and related topics like Melanoma and MedlinePlus Genetics have been removed, affecting page metadata and indexing rather than core content.
    Difference
    0.2%
    Check dated 2026-05-15T02:15:39.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page gains a Melanoma entry and a related topic MedlinePlus Genetics, along with a revision tag update to v3.5.3 and removal of the previous v3.5.2 entry.
    Difference
    0.2%
    Check dated 2026-04-30T16:55:34.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Removed a small set of related-topic link text (including “Melanoma” and MedlinePlus Genetics) from the study page.
    Difference
    0.2%
    Check dated 2026-04-23T14:56:16.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Melanoma was added to the related topics and MedlinePlus Genetics was added under related terms. The revision history shows the page version updated to v3.5.2 (replacing v3.5.0).
    Difference
    0.2%
    Check dated 2026-04-16T10:45:08.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Melanoma was removed from the conditions section and MedlinePlus Genetics was removed from related topics.
    Difference
    0.2%
    Check dated 2026-04-09T08:12:39.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision notes updated: added Revision v3.5.0 and removed Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T18:00:16.000Z thumbnail image

Stay in the know with updates to Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.